Large Cap Biopharma Stalled With Move to Small Caps and Reflation Trade By: TalkMarkets February 15, 2021 at 19:29 PM EST Defensive large-cap biopharma stocks stalled as traders moved out on the risk curve seeking faster gains. Read More >> Related Stocks: Bristol-Myers Squibb Eli Lilly FINANCIAL SEL Johnson & Johnson Merck & Co Russell 2000 Ishares ETF S&P Biotech SPDR S&P Pharmaceuticals SPDR Vertex Pharmaceuticals